Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Lima | Basic Materials | Metals & Mining | 29.9% | PEN 1.89B | 12.5x | 0.26 | PEN 11.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Lima | Basic Materials | Metals & Mining | 13.3% | PEN 440.63M | 3.8x | 0.03 | PEN 197.50 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Lima | Basic Materials | Metals & Mining | 10.4% | PEN 1.89B | 12.5x | 0.26 | PEN 7.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Lima | Basic Materials | Metals & Mining | 10.1% | PEN 4.14B | 3.2x | 0.04 | PEN 133 | 95.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Lima | Basic Materials | Metals & Mining | 1.8% | PEN 50.74B | 13.1x | 0.19 | PEN 144.41 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.2% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Lima | Healthcare | Biotechnology & Medical Research | 0.1% | PEN 202.34B | 12.6x | 0.74 | PEN 2,482.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |